On September 14, the Wall Street Journal published an important review article detailing the National Institutes of Health (NIH) research program that may lead to greater restrictions on structure / function and health claims made for Dietary Supplements. Due to copyright restrictions we cannot post the Wall Street Journal article. However, interested readers are able to access the article through Lexis/Nexis or the Wall Street Journal website. The article discusses ongoing grant funding for academic research institutions which is being provided by the NIH National Center for Complementary and Alternative Medicine (www.nccam.gov) and the NIH Office of Dietary Supplements (www.ods.gov).

In 2009, the Government Accountability Office published a study of the steps that FDA should take to exert greater control over the manufacture, labeling, and marketing of Dietary Supplements. This topic was addressed again in a May 2010 GAO study of marketing practices in the Dietary Supplement industry. These documents are posted below.